A detailed history of Coco Enterprises, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Coco Enterprises, LLC holds 3,741 shares of MRK stock, worth $388,278. This represents 0.3% of its overall portfolio holdings.

Number of Shares
3,741
Previous 3,741 -0.0%
Holding current value
$388,278
Previous $493,000 6.09%
% of portfolio
0.3%
Previous 0.33%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $113 - $131
1 Added 0.03%
3,741 $493,000
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $17,832 - $19,405
-178 Reduced 4.54%
3,740 $407,000
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $34,282 - $38,071
-333 Reduced 7.83%
3,918 $403,000
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $200,711 - $218,766
-1,848 Reduced 30.3%
4,251 $490,000
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $159,042 - $177,458
-1,545 Reduced 20.21%
6,099 $648,000
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $8,219 - $10,538
94 Added 1.25%
7,644 $848,000
Q3 2022

Nov 18, 2022

SELL
$84.53 - $94.96 $4,564 - $5,127
-54 Reduced 0.71%
7,550 $653,000
Q2 2022

Aug 10, 2022

SELL
$83.49 - $94.64 $109,288 - $123,883
-1,309 Reduced 14.69%
7,604 $693,000
Q1 2022

May 11, 2022

BUY
$73.51 - $82.4 $65,791 - $73,748
895 Added 11.16%
8,913 $737,000
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $25,298 - $31,689
350 Added 4.56%
8,018 $614,000
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $114,831 - $126,285
1,602 Added 26.41%
7,668 $576,000
Q2 2021

Jul 28, 2021

BUY
$70.31 - $77.77 $132,464 - $146,518
1,884 Added 45.05%
6,066 $472,000
Q1 2021

May 05, 2021

BUY
$68.86 - $81.11 $88,691 - $104,469
1,288 Added 44.51%
4,182 $322,000
Q4 2020

May 05, 2021

BUY
$71.77 - $79.65 $207,702 - $230,507
2,894 New
2,894 $237,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $263B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Coco Enterprises, LLC Portfolio

Follow Coco Enterprises, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coco Enterprises, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coco Enterprises, LLC with notifications on news.